Abbreviation: ANNA.
Any of several antibodies that bind to neuronal targets in the cerebrum and cerebellum, producing paraneoplastic neurological dysfunction. The antibodies are typically released by cancers such as small-cell carcinoma of the lung (anti-Hu antibody—also known as ANNA-1 and ANNA-2), testicular cancer (anti-Ta antibody), or breast cancer (ANNA-2).